Benzinga - Sotera Health Company (NASDAQ: SHC) shares are trading higher Monday after a Cook County jury ruled in favor of the company in a cancer case involving a woman's proximity to one of the company's plants.
What To Know: According to a local report, a Cook County jury has ruled that Sotera unit Sterigenics should bear no liability for cancer in a woman who spent decades living near the company's former plant.
The verdict was delivered late Friday and is just the second decision in a string of hundreds of cases still pending against the company over ethylene oxide emissions.
Related Link: What Does Sotera Health's Debt Look Like?
Earlier this year, a different jury ordered Sterigenics to pay $363 million to a different woman, making similar claims. This week's ruling is a complete contrast to the previous ruling and comes as a positive surprise for Sotera shareholders.
"The jury’s verdict in this matter reflects the careful consideration and understanding of the science and other evidence presented at trial," said a Sterigenics spokesperson following the verdict.
KeyBanc analysts called it a "major win" for Sotera Health.
SHC Price Action: Sotera has a 52-week high of $24.90 and a 52-week low of $5.78.
The stock was up 33.4% at $8.03 at time of publication, according to Benzinga Pro.
Photo: Daniel Bone from Pixabay.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.